More important, tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor binding protein 7 (IFGBP7) have recently been suggested as promising tools for the early detection of AKI in critically ill patients [10, 11]. Here, IGFBP7 is linked to acute kidney injury.